The neglected tropical diseases (NTDs) represent a group of parasitic and related infectious diseases such as amebiasis, Chagas disease, cysticercosis, echinococcosis, hookworm, leishmaniasis, and schistosomiasis. Together, these conditions are considered the most common infections in low- and middle-income countries, where they produce a level of global disability and human suffering equivalent to better known conditions such as human immunodeficiency virus/acquired immunodeficiency syndrome and malaria.
Despite their global public health importance, progress on developing vaccines for NTD pathogens has lagged because of some key technical hurdles and the fact that these infections occur almost exclusively in the world’s poorest people living below the World Bank poverty line. In the absence of financial incentives for new products, the multinational pharmaceutical companies have not embarked on substantive research and development programs for the neglected tropical disease vaccines. However, with the vaccine R&D pipeline in decline and the low hanging fruit all covered, could NTD vaccines be the next big move for Pharma and biotechs?
This ebook aims at giving you a comprehensive overview of this very niche vaccine industry field, looking at the market size and potential unmet needs and targets.
For more information about the topics discussed at the World Vaccine Congress Washington, please click here >